Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 41

1.

Fluoroquinolones and isoniazid-resistant tuberculosis: implications for the 2018 WHO guidance.

Stagg HR, Bothamley GH, Davidson JA, Kunst H, Lalor MK, Lipman MC, Loutet MG, Lozewicz S, Mohiyuddin T, Abbara A, Alexander E, Booth H, Creer DD, Harris RJ, Kon OM, Loebinger MR, McHugh TD, Milburn HJ, Palchaudhuri P, Phillips PPJ, Schmok E, Taylor L, Abubakar I; London INH-R TB study group.

Eur Respir J. 2019 Oct 10;54(4). pii: 1900982. doi: 10.1183/13993003.00982-2019. Print 2019 Oct.

2.

British Thoracic Society Guideline for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD).

Haworth CS, Banks J, Capstick T, Fisher AJ, Gorsuch T, Laurenson IF, Leitch A, Loebinger MR, Milburn HJ, Nightingale M, Ormerod P, Shingadia D, Smith D, Whitehead N, Wilson R, Floto RA.

BMJ Open Respir Res. 2017 Oct 19;4(1):e000242. doi: 10.1136/bmjresp-2017-000242. eCollection 2017. Review.

3.

British Thoracic Society guidelines for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD).

Haworth CS, Banks J, Capstick T, Fisher AJ, Gorsuch T, Laurenson IF, Leitch A, Loebinger MR, Milburn HJ, Nightingale M, Ormerod P, Shingadia D, Smith D, Whitehead N, Wilson R, Floto RA.

Thorax. 2017 Nov;72(Suppl 2):ii1-ii64. doi: 10.1136/thoraxjnl-2017-210927. Review. No abstract available.

PMID:
29054853
4.

An update on the management of latent tuberculosis infection and active disease in patients with chronic kidney disease.

Myall K, Milburn HJ.

Pol Arch Intern Med. 2017 Aug 24;127(10):681-686. doi: 10.20452/pamw.4093. Epub 2017 Aug 24. Review.

5.

Variation in vitamin D deficiency among tuberculosis patients by ethnic group and geographical region of birth: evidence from a diverse south London population.

Pilarski A, Penn N, Ratnakumar S, Barker RD, Milburn HJ.

Eur Respir J. 2016 Nov;48(5):1507-1510. doi: 10.1183/13993003.00057-2016. Epub 2016 Oct 6. No abstract available.

6.

Determinants of treatment-related paradoxical reactions during anti-tuberculosis therapy: a case control study.

Brown CS, Smith CJ, Breen RA, Ormerod LP, Mittal R, Fisk M, Milburn HJ, Price NM, Bothamley GH, Lipman MC.

BMC Infect Dis. 2016 Sep 6;16:479. doi: 10.1186/s12879-016-1816-4.

7.

Incidence of tuberculosis is high in chronic kidney disease patients in South East England and drug resistance common.

Ostermann M, Palchaudhuri P, Riding A, Begum P, Milburn HJ.

Ren Fail. 2016;38(2):256-61. doi: 10.3109/0886022X.2015.1128290. Epub 2016 Jan 4.

PMID:
26726960
8.

Point-of-care urine test for assessing adherence to isoniazid treatment for tuberculosis.

Soobratty MR, Whitfield R, Subramaniam K, Grove G, Carver A, O'Donovan GV, Wu HH, Lee OY, Swaminathan R, Cope GF, Milburn HJ.

Eur Respir J. 2014 May;43(5):1519-22. doi: 10.1183/09031936.00132613. Epub 2014 Jan 16. No abstract available.

9.

Ethnic variation in inflammatory profile in tuberculosis.

Coussens AK, Wilkinson RJ, Nikolayevskyy V, Elkington PT, Hanifa Y, Islam K, Timms PM, Bothamley GH, Claxton AP, Packe GE, Darmalingam M, Davidson RN, Milburn HJ, Baker LV, Barker RD, Drobniewski FA, Mein CA, Bhaw-Rosun L, Nuamah RA, Griffiths CJ, Martineau AR.

PLoS Pathog. 2013;9(7):e1003468. doi: 10.1371/journal.ppat.1003468. Epub 2013 Jul 4.

10.

The geographic diversity of nontuberculous mycobacteria isolated from pulmonary samples: an NTM-NET collaborative study.

Hoefsloot W, van Ingen J, Andrejak C, Angeby K, Bauriaud R, Bemer P, Beylis N, Boeree MJ, Cacho J, Chihota V, Chimara E, Churchyard G, Cias R, Daza R, Daley CL, Dekhuijzen PN, Domingo D, Drobniewski F, Esteban J, Fauville-Dufaux M, Folkvardsen DB, Gibbons N, Gómez-Mampaso E, Gonzalez R, Hoffmann H, Hsueh PR, Indra A, Jagielski T, Jamieson F, Jankovic M, Jong E, Keane J, Koh WJ, Lange B, Leao S, Macedo R, Mannsåker T, Marras TK, Maugein J, Milburn HJ, Mlinkó T, Morcillo N, Morimoto K, Papaventsis D, Palenque E, Paez-Peña M, Piersimoni C, Polanová M, Rastogi N, Richter E, Ruiz-Serrano MJ, Silva A, da Silva MP, Simsek H, van Soolingen D, Szabó N, Thomson R, Tórtola Fernandez T, Tortoli E, Totten SE, Tyrrell G, Vasankari T, Villar M, Walkiewicz R, Winthrop KL, Wagner D; Nontuberculous Mycobacteria Network European Trials Group.

Eur Respir J. 2013 Dec;42(6):1604-13. doi: 10.1183/09031936.00149212. Epub 2013 Apr 18.

11.
12.

Non-tuberculous slow-growing mycobacterial pulmonary infections in non-HIV-infected patients in south London.

Davies BS, Roberts CH, Kaul S, Klein JL, Milburn HJ.

Scand J Infect Dis. 2012 Nov;44(11):815-9. doi: 10.3109/00365548.2012.694469.

PMID:
23078529
13.

Vitamin D accelerates resolution of inflammatory responses during tuberculosis treatment.

Coussens AK, Wilkinson RJ, Hanifa Y, Nikolayevskyy V, Elkington PT, Islam K, Timms PM, Venton TR, Bothamley GH, Packe GE, Darmalingam M, Davidson RN, Milburn HJ, Baker LV, Barker RD, Mein CA, Bhaw-Rosun L, Nuamah R, Young DB, Drobniewski FA, Griffiths CJ, Martineau AR.

Proc Natl Acad Sci U S A. 2012 Sep 18;109(38):15449-54. Epub 2012 Sep 4.

14.

Drug-induced hypothyroidism in patients receiving treatment for multidrug-resistant tuberculosis in the UK.

Gupta J, Breen RA, Milburn HJ.

Int J Tuberc Lung Dis. 2012 Sep;16(9):1278. doi: 10.5588/ijtld.12.0305. No abstract available.

PMID:
22871328
15.

A new point of care cotinine test for saliva to identify and monitor smoking habit.

Cope GF, Wu HH, O'Donovan GV, Milburn HJ.

Eur Respir J. 2012 Aug;40(2):496-7. doi: 10.1183/09031936.00219011. No abstract available.

16.

High-dose vitamin D(3) during intensive-phase antimicrobial treatment of pulmonary tuberculosis: a double-blind randomised controlled trial.

Martineau AR, Timms PM, Bothamley GH, Hanifa Y, Islam K, Claxton AP, Packe GE, Moore-Gillon JC, Darmalingam M, Davidson RN, Milburn HJ, Baker LV, Barker RD, Woodward NJ, Venton TR, Barnes KE, Mullett CJ, Coussens AK, Rutterford CM, Mein CA, Davies GR, Wilkinson RJ, Nikolayevskyy V, Drobniewski FA, Eldridge SM, Griffiths CJ.

Lancet. 2011 Jan 15;377(9761):242-50. doi: 10.1016/S0140-6736(10)61889-2. Epub 2011 Jan 5.

18.

The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement.

Solovic I, Sester M, Gomez-Reino JJ, Rieder HL, Ehlers S, Milburn HJ, Kampmann B, Hellmich B, Groves R, Schreiber S, Wallis RS, Sotgiu G, Schölvinck EH, Goletti D, Zellweger JP, Diel R, Carmona L, Bartalesi F, Ravn P, Bossink A, Duarte R, Erkens C, Clark J, Migliori GB, Lange C.

Eur Respir J. 2010 Nov;36(5):1185-206. doi: 10.1183/09031936.00028510. Epub 2010 Jun 7.

19.

Reactivation of tuberculosis and vitamin D deficiency: the contribution of diet and exposure to sunlight.

Sita-Lumsden A, Lapthorn G, Swaminathan R, Milburn HJ.

Thorax. 2007 Nov;62(11):1003-7. Epub 2007 May 25.

20.

Current difficulties in the diagnosis and management of spinal tuberculosis.

Cormican L, Hammal R, Messenger J, Milburn HJ.

Postgrad Med J. 2006 Jan;82(963):46-51.

21.

G-CSF enables completion of tuberculosis therapy associated with iatrogenic neutropenia.

Cormican LJ, Schey S, Milburn HJ.

Eur Respir J. 2004 Apr;23(4):649-50.

22.

Management of multiple drug-resistant tuberculosis.

Hutchison DC, Drobniewski FA, Milburn HJ.

Respir Med. 2003 Jan;97(1):65-70.

23.

Primary tuberculosis.

Milburn HJ.

Curr Opin Pulm Med. 2001 May;7(3):133-41. Review.

PMID:
11371768
24.

High incidence of primary tuberculosis.

Milburn HJ, Gibilaro J, Atkinson H, Heathcock R.

Arch Dis Child. 2000 May;82(5):386-7.

25.

Papulonecrotic tuberculide complicating scrofuloderma in a health-care worker.

Almeida BM, Challacombe SJ, Hay RJ, Morgan PR, Milburn HJ.

Br J Dermatol. 1998 Sep;139(3):550-2. No abstract available.

PMID:
9767317
26.

Effect of sex of fetus on asthma during pregnancy: blind prospective study.

Beecroft N, Cochrane GM, Milburn HJ.

BMJ. 1998 Sep 26;317(7162):856-7. No abstract available.

27.

An outbreak of multi-drug-resistant tuberculosis in a London teaching hospital.

Breathnach AS, de Ruiter A, Holdsworth GM, Bateman NT, O'Sullivan DG, Rees PJ, Snashall D, Milburn HJ, Peters BS, Watson J, Drobniewski FA, French GL.

J Hosp Infect. 1998 Jun;39(2):111-7.

PMID:
9651855
28.

Compliance and concordance with treatment. Treating the patient as a decision maker is not always appropriate.

Milburn HJ, Cochrane GM.

BMJ. 1997 Jun 28;314(7098):1906. No abstract available.

29.

Corticosteroids restore the balance between locally produced Th1 and Th2 cytokines and immunoglobulin isotypes to normal in sarcoid lung.

Milburn HJ, Poulter LW, Dilmec A, Cochrane GM, Kemeny DM.

Clin Exp Immunol. 1997 Apr;108(1):105-13.

30.

Abnormal alveolar macrophage populations in bone marrow transplant recipients with pneumonitis.

Milburn HJ, Prentice HG, Poulter LW.

Eur Respir J. 1993 Oct;6(9):1295-300.

PMID:
8287945
31.

IgG subclasses in the lungs of patients with interstitial pneumonitis following bone marrow transplantation.

Milburn HJ, Prentice HG, Grundy JE.

Eur Respir J. 1993 Jul;6(7):944-50.

PMID:
8370442
33.

Lymphocyte subsets in hypersensitivity pneumonitis.

Milburn HJ.

Eur Respir J. 1992 Jan;5(1):5-7. No abstract available.

PMID:
1577149
34.

Pneumonitis in bone marrow transplant recipients results from a local immune response.

Milburn HJ, Du Bois RM, Prentice HG, Poulter LW.

Clin Exp Immunol. 1990 Aug;81(2):232-7.

35.

Controlled trial of natamycin in the treatment of allergic bronchopulmonary aspergillosis.

Currie DC, Lueck C, Milburn HJ, Harvey C, Longbottom JL, Darbyshire JH, Nunn AJ, Cole PJ.

Thorax. 1990 Jun;45(6):447-50.

36.

Pulmonary cell populations in recipients of bone marrow transplants with interstitial pneumonitis.

Milburn HJ, Poulter LW, Prentice HG, du Bois RM.

Thorax. 1989 Jul;44(7):570-5.

37.

Is the measurement of virus-specific antibody in the lungs of transplant recipients with cytomegalovirus pneumonitis of diagnostic or prognostic value?

Milburn HJ, Grundy JE, du Bois RM, Prentice HG, Griffiths PD.

J Med Virol. 1988 Oct;26(2):197-206.

PMID:
2846778
38.

Humoral immune responses within the lung of bone marrow transplant recipients studied by bronchoalveolar lavage.

Milburn HJ, Grundy JE, du Bois RM, Prentice HG, Griffiths PD.

Clin Exp Immunol. 1988 May;72(2):309-14.

39.
40.
41.

Atopy and rheumatoid arthritis.

O'Driscoll BR, Milburn HJ, Kemeny DM, Cochrane GM, Panayi GS.

Clin Allergy. 1985 Nov;15(6):547-53.

PMID:
3907887

Supplemental Content

Loading ...
Support Center